| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
12,090,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
4,012,246 |
Avg
Vol: |
4,001,203 |
| 52
Week Range: |
$0.1961 - $0.4503 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aethlon Medical is a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases. The Aethlon Hemopurifier® (Hemopurifier) is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. Co. is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Joyce James A |
CEO, Secretary |
• • – |
2018-04-30 |
4 |
OE |
$1.34 |
$25,153 |
D/D |
18,771 |
175,004 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-04-30 |
4 |
OE |
$1.34 |
$1,780 |
D/D |
1,328 |
14,783 |
|
- |
|
| Johnson Sabrina Martucci |
Director |
– • – |
2018-03-31 |
4 |
D |
$1.19 |
$19,349 |
D/D |
(16,260) |
24,390 |
|
- |
|
| Johnson Sabrina Martucci |
Director |
– • – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
40,650 |
40,650 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-01-31 |
4/A |
D |
$1.50 |
$2,786 |
D/D |
(1,857) |
41,340 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2018-01-31 |
4 |
OE |
$1.50 |
$2,394 |
D/D |
1,596 |
15,197 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-01-31 |
4 |
OE |
$1.50 |
$2,090 |
D/D |
1,393 |
13,455 |
|
- |
|
| Joyce James A |
CEO, Secretary |
• • – |
2018-01-31 |
4 |
OE |
$1.50 |
$25,469 |
D/D |
16,979 |
156,233 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2017-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
139,254 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2017-10-30 |
4 |
OE |
$0.98 |
$18,697 |
D/D |
19,079 |
155,254 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-10-30 |
4 |
OE |
$0.98 |
$1,534 |
D/D |
1,565 |
12,062 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2017-10-30 |
4 |
OE |
$0.98 |
$1,733 |
D/D |
1,768 |
13,601 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2017-10-11 |
4 |
OE |
$1.14 |
$21,750 |
D/D |
19,079 |
136,175 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2017-10-11 |
4 |
OE |
$1.14 |
$2,016 |
D/D |
1,768 |
11,833 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-10-11 |
4 |
OE |
$1.14 |
$1,784 |
D/D |
1,565 |
10,497 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-09-28 |
4/A |
D |
$1.14 |
$1,921 |
D/D |
(1,685) |
43,197 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2017-05-01 |
4 |
OE |
$2.23 |
$4,007 |
D/D |
1,797 |
10,065 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2017-05-01 |
4 |
OE |
$2.23 |
$42,546 |
D/D |
19,079 |
117,096 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-05-01 |
4 |
OE |
$2.23 |
$3,555 |
D/D |
1,594 |
8,932 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-04-30 |
4/A |
D |
$2.23 |
$3,693 |
D/D |
(1,656) |
44,882 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2017-02-07 |
4 |
OE |
$4.28 |
$35,387 |
D/D |
8,268 |
8,268 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2017-02-07 |
4 |
OE |
$4.28 |
$419,898 |
D/D |
98,107 |
98,107 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-02-07 |
4 |
OE |
$4.28 |
$31,407 |
D/D |
7,338 |
7,338 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2017-01-31 |
4/A |
D |
$4.28 |
$24,233 |
D/D |
(5,662) |
46,538 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2016-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
821 |
13,861 |
|
- |
|
181 Records found
|
|
Page 5 of 8 |
|
|
